AP
GSK icon

Anchyra Partners’s GSK GSK Stock Holding History

Anchyra Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Buy
5,522
+18
+0.3% +$952 0.07% 247
2026
Q1 		$304K Sell
5,504
-32
-0.6% -$1.73K 0.09% 205
2025
Q4 		$271K Buy
+5,536
New +$258K 0.08% 211

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Anchyra Partners's GSK Position: Q2 2026 in Review

Anchyra Partners increased its GSK (GSK) stake by 0.33% in Q2 2026, buying an estimated $952 and bringing the position to 5,522 shares worth $289K. The position accounts for 0.07% of the portfolio, ranked #247.

Anchyra Partners first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $304K in Q1 2026. 627 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Anchyra Partners held 5,522 shares of GSK worth $289K as of Q2 2026.
  • Anchyra Partners bought 18 GSK shares in Q2 2026, an estimated $952.
  • GSK made up 0.07% of Anchyra Partners's portfolio in Q2 2026, its #247 holding.
  • Anchyra Partners first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Anchyra Partners's GSK position peaked at $304K in Q1 2026.
  • 627 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.